Neoadjuvant with low-dose radiotherapy, tislelizumab, albumin-bound paclitaxel, and cisplatin for resectable locally advanced head and neck squamous cell carcinoma: phase II single-arm trial
低剂量放疗、替雷利珠单抗、白蛋白结合型紫杉醇和顺铂新辅助治疗可切除局部晚期头颈部鳞状细胞癌：II期单臂试验
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-59865-1
Liu, Zhigang; Wang, Dong; Li, Guanjun; Yi, Muhua; Zhang, Zhaoyuan; Zhong, Guihua; Xu, Liangfu; Jiang, Rong; Zheng, Yannan; Huang, Linxuan; Peng, Yingpeng; Liang, Lizhong; Li, Jianpeng; Liu, Ye; Lai, Jun; Lv, Xianjuan; Xu, Yongqiang; Liu, Qiaodan; Wang, Zhiqiang; Liu, Zhutian; Yang, Qinan; Nie, Li; Lei, Jiao; Huang, Xiaotao; Liu, Zhijie; Jiang, Wen
